MediPal Holdings Corporation
Notice Regarding Decision on Treasury Stock Acquisition and Cancellation
The Company resolved at the Board of Directors meeting to acquire and cancel treasury stock. Acquisition cap is 4,000,000 shares (2.0% of outstanding shares), total amount up to 10 billion yen via market purchases, period from 2026/11/6 to 2027/3/31, and cancellation will be carried out after completion of acquisitions by March 31, 2027.
Key Figures
- Total number of treasury shares to be acquired: 4,000,000 shares (cap)
- Total acquisition price of shares: 10 billion yen (cap)
- Acquisition period: 2026/11/6 〜 2027/3/31
AI要約
Overview
MediPal Holdings Corporation resolved at the Board of Directors meeting held on October 23, 2026, to acquire and cancel treasury stock. The target is common shares, with an upper limit of 4,000,000 shares (cap of 2.0% of outstanding shares), and a total amount up to 10 billion yen to be purchased on the market from November 6, 2026 to March 31, 2027. The acquired shares will be cancelled. This is based on a policy aimed at improving capital efficiency and returning value to shareholders.
Impact on Shareholders and Future Outlook
Funds for the acquisition will be sourced from gains on sales of marketable securities and the funds described in the notice regarding revisions to full-year earnings guidance. The cancellation will reduce the number of outstanding shares and is expected to improve per-share metrics. Depending on market conditions during the acquisition period, shareholder returns may be further enhanced.
MediPal Holdings Corporation
Company overview · Stock price · Financial data · All IR
